Leerink Partners analyst Seamus Fernandez reiterated an Outperform rating and bumped its price target on Seattle Genetics (NASDAQ: SGEN) to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE